Bli medlem
Bli medlem

Du är här

2016-02-23

Oxford Immunotec to Present at the Cowen and Company 36th Annual Health Care Conference

Oxford Immunotec
Press release

Oxford Immunotec to Present at the Cowen and Company 36th Annual Health Care
Conference

OXFORD, United Kingdom and MARLBOROUGH, Mass., 2016-02-23 16:34 CET (GLOBE
NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global,
commercial-stage diagnostics company focused on developing and commercializing
proprietary tests for the management of immune-regulated conditions, today
announced that Dr. Peter Wrighton-Smith, Chief Executive Officer, and Richard
Altieri, Chief Financial Officer, will present at the Cowen and Company 36th
Annual Health Care Conference on Tuesday, March 8, 2016, at 9:20 a.m. EST at
the Boston Marriott Copley Place in Boston, MA.

A live webcast of the presentation will be available online from the investor
relations page of the Company's corporate website at www.oxfordimmunotec.com.
A webcast replay will be available approximately 24 hours after the live
presentation and will be archived on the website for approximately 60 days.

About Oxford Immunotec

Oxford Immunotec Global PLC is a global, commercial-stage diagnostics company
focused on developing and commercializing proprietary tests for the management
of immune-regulated conditions. The Company's first product is the T-SPOT?.TB
test, which is used to test for tuberculosis infection. The T-SPOT.TB test has
been approved for sale in over 50 countries, including the United States, where
it has received pre-market approval from the Food and Drug Administration,
Europe, where it has obtained a CE mark, as well as Japan and China. The
T-SPOT.CMV test and the T-SPOT.PRT test are the Company's second and third
products and part of a series of products intended for the transplantation
market. In addition to these three products, the Company has an additional six
active development programs, each of which leverages our T cell, B cell and
innate immune measuring technology. The Company is headquartered near Oxford,
U.K. and in Marlborough, Mass. Additional information can be found at
www.oxfordimmunotec.com.

T-SPOT and the Oxford Immunotec logo are trademarks of Oxford Immunotec Ltd.

CONTACTS:

For Media Inquiries:
Caroline Crawley
Oxford Immunotec
Tel: +44 1235 442796
ccrawley@oxfordimmunotec.com

For Investor Inquiries:
Rick Altieri
Chief Financial Officer
Oxford Immunotec
Tel: +1 (508) 573-9953
raltieri@oxfordimmunotec.com

Mark Klausner
Westwicke Partners
Tel: +1 (443) 213-0500
oxfordimmunotec@westwicke.com

Författare SSE

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.